BioNTech’s Bold Bet: From Vaccine Triumph to the Frontier of Cancer Treatment
BioNTech is shifting focus from COVID-19 vaccines to pioneering cancer therapies, highlighting resilience despite financial challenges. The company reported a noticeable drop in earnings amidst a transition period, with a…